PL1735013T3 - Cząstki hydroksyapatytu alfa- i beta-emitujące - Google Patents

Cząstki hydroksyapatytu alfa- i beta-emitujące

Info

Publication number
PL1735013T3
PL1735013T3 PL05708405T PL05708405T PL1735013T3 PL 1735013 T3 PL1735013 T3 PL 1735013T3 PL 05708405 T PL05708405 T PL 05708405T PL 05708405 T PL05708405 T PL 05708405T PL 1735013 T3 PL1735013 T3 PL 1735013T3
Authority
PL
Poland
Prior art keywords
beta
alpha
hydroxyapatite particles
emitting
emitting hydroxyapatite
Prior art date
Application number
PL05708405T
Other languages
English (en)
Inventor
Gro Salberg
Roy Larsen
Original Assignee
Algeta Asa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB0403856.8A external-priority patent/GB0403856D0/en
Application filed by Algeta Asa filed Critical Algeta Asa
Publication of PL1735013T3 publication Critical patent/PL1735013T3/pl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/12—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by a special physical form, e.g. emulsion, microcapsules, liposomes, characterized by a special physical form, e.g. emulsions, dispersions, microcapsules
    • A61K51/1241—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by a special physical form, e.g. emulsion, microcapsules, liposomes, characterized by a special physical form, e.g. emulsions, dispersions, microcapsules particles, powders, lyophilizates, adsorbates, e.g. polymers or resins for adsorption or ion-exchange resins
    • A61K51/1244—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by a special physical form, e.g. emulsion, microcapsules, liposomes, characterized by a special physical form, e.g. emulsions, dispersions, microcapsules particles, powders, lyophilizates, adsorbates, e.g. polymers or resins for adsorption or ion-exchange resins microparticles or nanoparticles, e.g. polymeric nanoparticles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Physics & Mathematics (AREA)
  • Optics & Photonics (AREA)
  • Engineering & Computer Science (AREA)
  • Nanotechnology (AREA)
  • Dispersion Chemistry (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Cosmetics (AREA)
PL05708405T 2004-02-20 2005-02-18 Cząstki hydroksyapatytu alfa- i beta-emitujące PL1735013T3 (pl)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
GBGB0403856.8A GB0403856D0 (en) 2004-02-20 2004-02-20 Composition
US54687804P 2004-02-23 2004-02-23
EP05708405A EP1735013B1 (en) 2004-02-20 2005-02-18 Alpha- and beta-emitting hydroxyapatite particles
PCT/GB2005/000616 WO2005079867A2 (en) 2004-02-20 2005-02-18 Alpha-emitting hydroxyapatite particles

Publications (1)

Publication Number Publication Date
PL1735013T3 true PL1735013T3 (pl) 2012-07-31

Family

ID=34889141

Family Applications (1)

Application Number Title Priority Date Filing Date
PL05708405T PL1735013T3 (pl) 2004-02-20 2005-02-18 Cząstki hydroksyapatytu alfa- i beta-emitujące

Country Status (8)

Country Link
US (1) US8142758B2 (pl)
EP (1) EP1735013B1 (pl)
AU (1) AU2005215234B2 (pl)
BR (1) BRPI0507824A (pl)
CA (1) CA2555435C (pl)
EA (1) EA020542B1 (pl)
PL (1) PL1735013T3 (pl)
WO (1) WO2005079867A2 (pl)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2007008232A2 (en) * 2004-09-03 2007-01-18 Board Of Regents, The University Of Texas System Locoregional internal radionuclide ablation of abnormal tissues.
US20070009436A1 (en) * 2005-07-08 2007-01-11 Rondinone Adam J Radionuclide nanoparticles encased by inorganic shell having vector biomolecules attached thereto
CN101125208B (zh) * 2007-08-03 2011-08-31 华中科技大学 一种磷灰石显影剂的制备方法
GB201002508D0 (en) 2010-02-12 2010-03-31 Algeta As Product
GB201009455D0 (en) 2010-06-04 2010-07-21 King S College London Nanoparticles and their uses in molecular imaging
US9849200B2 (en) 2010-09-16 2017-12-26 Mo-Sci Corporation Strontium phosphate microparticle for radiological imaging and therapy
US8865123B1 (en) * 2010-09-16 2014-10-21 Mo-Sci Corporation Strontium phosphate microparticle for radiological imaging and therapy
CA2870188A1 (en) 2012-04-12 2013-10-17 Howard University Polylactide and calcium phosphate compositions and methods of making the same
US8993978B2 (en) 2012-05-04 2015-03-31 Honeywell International Inc. Method for assessing an alpha particle emission potential of A metallic material
FR2990956B1 (fr) * 2012-05-24 2014-07-04 Areva Med Sas Procede et appareil pour la production de plomb 212 a usage medical
AU2013342209B2 (en) 2012-11-09 2016-05-26 Colgate-Palmolive Company Block copolymers for tooth enamel protection
US10117874B2 (en) 2013-12-03 2018-11-06 Bayer Pharma Aktiengesellschaft Combination of PI3K-inhibitors
WO2015082378A1 (en) 2013-12-03 2015-06-11 Bayer Pharma Aktiengesellschaft Combination of pi3k-inhibitors
CN103706385B (zh) * 2014-01-23 2015-09-09 河南理工大学 Fe3O4/SiO2/分子印迹羟基磷灰石核壳结构纳米复合光催化剂及其制备方法
WO2015149070A1 (en) * 2014-03-28 2015-10-01 Washington University Hydrogels for localized radiotherapy
NO3061464T3 (pl) * 2015-02-26 2018-03-24
US9433690B1 (en) 2015-02-26 2016-09-06 Sciencons AS Radiopharmaceutical solutions with advantageous properties
SG11201706849SA (en) * 2015-02-26 2017-09-28 Sciencons AS Radiopharmaceutical solutions with advantageous properties
PT3111959T (pt) * 2015-07-03 2017-12-14 Oncoinvent As Partículas e suspensões radioterapêuticas
US20170065731A1 (en) * 2015-09-06 2017-03-09 Medical Theranostics Inc. Method, Apparatus, and System for Radiation Therapy
JP7544819B2 (ja) 2019-12-05 2024-09-03 サイエンコンス アクスイェ セルスカプ 高度に精製された２１２Ｐｂの製造
CN111115609A (zh) * 2019-12-23 2020-05-08 华中科技大学鄂州工业技术研究院 一种Sr-Fe共掺杂HAP纳米颗粒及其制备方法
CA3192409A1 (en) * 2020-09-15 2022-03-24 Jan A. Alfheim Preparations of radium-224 and progenies for use in radionuclide therapy in combination with dna repair inhibitors
CN120057878B (zh) * 2024-05-14 2025-11-25 重庆大学 基于同质原位替代法制备的双核素标记纳米羟基磷灰石

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5085848A (en) * 1989-05-30 1992-02-04 The United States Of America As Represented By The United States Department Of Energy Method of treating inflammatory diseases using a radiolabeled ferric hydroxide calloid
US4970062A (en) * 1989-05-30 1990-11-13 The United States Of America As Represented By The United States Department Of Energy Colloid labelled with radionuclide and method
US5137709A (en) * 1991-02-15 1992-08-11 The Dow Chemical Company Layered mixed metal hydroxides for the stabilization of radioactive colloids
US5344640A (en) * 1991-10-22 1994-09-06 Mallinckrodt Medical, Inc. Preparation of apatite particles for medical diagnostic imaging
WO1997001304A1 (en) * 1995-06-29 1997-01-16 Mallinckrodt Medical, Inc. Radiolabeled apatite particles containing a paramagnetic ion
AU1064800A (en) * 1998-11-12 2000-06-05 Nycomed Amersham Plc Products and methods
NO310544B1 (no) * 1999-01-04 2001-07-23 Algeta As Opparbeidelse og anvendelse av radium-223 til fremstilling av preparat samt kit til behandling av kalsifisert vev for palliasjon, benkreft-terapi og/eller overflatebehandling av ben
BR0014877A (pt) * 1999-10-18 2002-06-11 Ferx Inc Veìculo magnético objetivado composto de ferro e materiais porosos para a distribuição objetivada de agentes biologicamente ativos
NO314537B1 (no) * 1999-12-06 2003-04-07 Anticancer Therapeutic Inv Sa Reseptorbindende konjugater
NO312708B1 (no) * 2000-02-21 2002-06-24 Anticancer Therapeutic Inv Sa Radioaktive liposomer til terapi
NO313180B1 (no) * 2000-07-04 2002-08-26 Anticancer Therapeutic Inv Sa Bensökende alfapartikkel emitterende radiofarmasöytika
GB0213261D0 (en) * 2002-06-10 2002-07-17 Anticancer Therapeutic Inv Sa Method
GB0308731D0 (en) * 2003-04-15 2003-05-21 Anticancer Therapeutic Inv Sa Method of radiotherapy
US20060228297A1 (en) * 2003-04-15 2006-10-12 Roy Larsen Thorium-227 for use in radiotherapy of soft tissue disease
US20040258614A1 (en) * 2003-06-20 2004-12-23 University Of Maryland, Baltimore Microparticles for microarterial imaging and radiotherapy

Also Published As

Publication number Publication date
CA2555435A1 (en) 2005-09-01
EA020542B1 (ru) 2014-12-30
WO2005079867A3 (en) 2006-03-16
CA2555435C (en) 2011-07-12
EA200601524A1 (ru) 2007-02-27
EP1735013A2 (en) 2006-12-27
EP1735013B1 (en) 2012-02-08
WO2005079867A2 (en) 2005-09-01
BRPI0507824A (pt) 2007-07-10
AU2005215234B2 (en) 2009-02-19
US8142758B2 (en) 2012-03-27
US20080226547A1 (en) 2008-09-18
AU2005215234A1 (en) 2005-09-01

Similar Documents

Publication Publication Date Title
PL1735013T3 (pl) Cząstki hydroksyapatytu alfa- i beta-emitujące
EP1879528A4 (en) DISC PROSTHESIS
IL184068A (en) Intervertebral disc prosthesis
PL1711133T3 (pl) Proteza krążka międzykręgowego
ZA200707133B (en) Intervertebral disc restoration
IL178842A0 (en) Intervertebral disc prothesis
EP1929467A4 (en) PROSTHETIC BANDS
EP1711131A4 (en) FEMORO-PATELLAR PROSTHESIS
GB2420499B (en) Spinal prostheses
EP1627367A4 (en) PARTICLE DETECTOR
ZA200702476B (en) Inter-vetebral disc prosthesis
EP1968526A4 (en) FOAMING DENTAL COMPOSITIONS AND METHODS
GB0422231D0 (en) Synthetic prosthesis
IL177744A0 (en) Aptamers and pharmaceutical compositions containing the same
EP1699435A4 (en) PARTICLE
GB0300983D0 (en) Brake disc
GB2411839B (en) Prosthesis
GB0423415D0 (en) Prosthesis
GB0222344D0 (en) Graded particulate composition
GB0515625D0 (en) Hydrogel particle
GB0401846D0 (en) Novel particles
GB0418399D0 (en) Prosthesis
GB2426304B (en) Brake disc
GB0300739D0 (en) Disc container
GB0413338D0 (en) Polymeric particles